First multicenter, randomized controlled trial directly comparing a new technology to robotic RP for men with localized prostate cancer to ...

InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that its Board of Directors has authorized a new share repurchase program for up to ...

LOS GATOS, CA / ACCESS Newswire / March 12, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacro-pelvic disorders, ...

Discusses First Clinical Outcomes and Precision of TULSA from the CAPTAIN Trial in Prostate Cancer March 13, 2026 11:30 ...

Enrollment begins in the FDA-authorized FINALE pivotal trial evaluating FemBloc, a first-of-its-kind non-surgical permanent birth control, following positive clinical data -- ...

Women who used fertility treatments had no higher overall risk of invasive cancer than other women, a large Australian study led by researchers from UNSW Sydney has found. The study, published in JAMA ...

New UAB research uncovers how NFAT helps uterine NK cells support early placenta development, shedding light on pregnancy health and the roots of complications like preeclampsia.

(MENAFN- GlobeNewsWire - Nasdaq) [220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Viral Vaccine Cell Culture Media ...

Ltd. ("Autozi" or the "Company") today announced that the Company's controlling shareholder has fulfilled its previous commitment by injecting $7 million, with all funds now fully received. This ...

A new mother recently shared her concerns about experiencing pain during sex months after giving birth, wondering if her recovery is progressing normally. Her story has resonated with countless women ...